Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer

被引:75
作者
Ahn, B. Y. [1 ,2 ]
Trinh, D. L. N. [1 ,2 ]
Zajchowski, L. D. [4 ]
Lee, B. [1 ,2 ]
Elwi, A. N. [1 ,2 ]
Kim, S-W [1 ,2 ,3 ,4 ]
机构
[1] Univ Calgary, Dept Biochem, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Mol Biol, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada
[4] Univ Calgary, Clark H Smith Brain Tumour Ctr, Calgary, AB T2N 4N1, Canada
关键词
p53; Tid1; tumor suppressor; mitochondria; apoptosis; MUTANT P53; MEMBRANE PERMEABILIZATION; MEDIATED APOPTOSIS; DNA-DAMAGE; CELLS; ACTIVATION; BAX; PROTEIN; DEGRADATION; CHAPERONES;
D O I
10.1038/onc.2009.413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein induces apoptosis in response to genotoxic and environmental stresses. Recent studies have revealed the existence of a transcription-independent mitochondrial p53 apoptotic pathway; however, the mechanism that regulates its translocation to the mitochondria has been unknown. In this study, we show that the tumor suppressor Tid1 forms a complex with p53 under hypoxic conditions that directs p53 translocation to the mitochondria and the subsequent initiation of the mitochondrial apoptosis pathway. Loss of Tid1 expression abrogated p53 translocation to the mitochondria and inhibited apoptosis, whereas the over-expression of Tid1 promoted p53 mitochondrial localization and apoptosis. Tid1's mitochondrial signal sequence and DnaJ domain were both required for the movement of the p53-Tid1 complex from the cytosol to the mitochondria. When Tid is over-expressed in cancer cell lines expressing mutant p53 isoforms defective in transcriptional activity, mitochondrial localization and pro-apoptotic activities of the mutant p53 proteins was restored. Our results establish Tid1 as a novel regulator of p53-mediated apoptosis, and suggest that therapies designed to enhance Tid1's function in promoting mitochondrial localization of p53 and apoptosis could be an effective therapy in many cancers. Oncogene (2010) 29, 1155-1166; doi: 10.1038/onc.2009.413; published online 23 November 2009
引用
收藏
页码:1155 / 1166
页数:12
相关论文
共 37 条
[11]   Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides [J].
Gomez, J. A. ;
Gama, V. ;
Yoshida, T. ;
Sun, W. ;
Hayes, P. ;
Leskovll, K. ;
Boothman, D. ;
Matsuyama, S. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :797-801
[12]   The role of p53 in hypoxia-induced apoptosis [J].
Hammond, EM ;
Giaccia, AJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) :718-725
[13]   Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[14]   INDUCTION OF APOPTOSIS IN HELA-CELLS BY TRANS-ACTIVATION-DEFICIENT P53 [J].
HAUPT, Y ;
ROWAN, S ;
SHAULIAN, E ;
VOUSDEN, KH ;
OREN, M .
GENES & DEVELOPMENT, 1995, 9 (17) :2170-2183
[15]  
HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571
[16]   Desferrioxamine (DFX) has genotoxic effects on cultured human lymphocytes and induces the p53-mediated damage response [J].
Kim, Byeong Mo ;
Choi, Jun Yeol ;
Kim, Yang Jee ;
Woo, Hae Dong ;
Chung, Hai Won .
TOXICOLOGY, 2007, 229 (03) :226-235
[17]   Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interieukin-8 [J].
Kim, SW ;
Hayashi, M ;
Lo, JF ;
Fearns, C ;
Xiang, R ;
Lazennec, G ;
Yang, Y ;
Lee, JD .
CANCER RESEARCH, 2005, 65 (19) :8784-8791
[18]   Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells [J].
Kim, SW ;
Chao, TH ;
Xiang, R ;
Lo, JF ;
Campbell, MJ ;
Fearns, C ;
Lee, JD .
CANCER RESEARCH, 2004, 64 (21) :7732-7739
[19]   Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp9O interactions with wild-type or mutant p53 [J].
King, FW ;
Wawrzynow, A ;
Höhfeld, J ;
Zylicz, M .
EMBO JOURNAL, 2001, 20 (22) :6297-6305
[20]   A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function [J].
Kokontis, JM ;
Wagner, AJ ;
O'Leary, M ;
Liao, S ;
Hay, N .
ONCOGENE, 2001, 20 (06) :659-668